Intracellular [Ca21] transients were studied in isolated hearts of healthy and cardiomyopathic hamsters in late failure perfused with glucose or pyruvate. Hearts of healthy hamsters developed similar pressures when perfused with either glucose or pyruvate, and [Ca2]i; transients were comparable in amplitude when perfused with either substrate. On the other hand, hearts of cardiomyopathic hamsters in late failure developed normal pressure when perfused with pyruvate but developed depressed pressure (509%) when perfused with glucose. The amplitude of [Ca2]i transients fell severely and was associated with a high diastolic [Ca21]1 in cardiomyopathic hamster hearts when the perfusate was switched from pyruvate to glucose. The high phosphomonoester sugars as evidenced by 31P nuclear magnetic resonance studies and the depressed oxygen consumption in the cardiomyopathic hamster hearts perfused with glucose reflect an inhibition in glycolysis and a subsequent decrease in mitochondrial activity. Without an adequate delivery of substrate to the mitochondria in the cardiomyopathic hamster, the myocardium is no longer capable of maintaining its [Ca211 homeostasis. (Circulation Research 1991;68:45-51) From the
I mpaired mechanical performance is the usual cause of congestive heart failure, although diastolic dysfunction may play an important contributory role.' Changes in the failing myocardium of the myopathic hamster include a deficient production in cyclic AMP,2 a decrease in Na+,K+-ATPase,3 a decrease in the function of the sarcoplasmic reticulum,4 an inhibition in the NaW/Ca2' exchanger,5 excessive calcium accumulation,6'7 fibrosis,8 high inorganic phosphate,9 and a depressed phosphorylation potential. 10 The studies described here were carried out to determine if the decrease in cardiac performance observed in the cardiomyopathic hamster heart perfused with glucose as the substrate'0 was associated with a decrease in the amplitude of calcium transients and an increase in diastolic [Ca2] . To assess [Ca2] i transients, the fluorescent dye indo 1 and surface fluorometry were used as described previously. [11] [12] [13] [14] 
Materials and Methods Animals
Twenty-four Syrian cardiomyopathic hamsters (UM-X7.1 strain, a derivative of the Bio 14.6 strain) in late failure (220-240 days of age) and 24 Syrian age-matched healthy hamsters were studied. Cardiomyopathic hamsters are in severe advanced heart failure at 250 days of age, and all animals die by 280-300 days because of myocardial pump failure or arrhythmias. All animals contained ascites fluid in the abdominal cavity and thrombotic material in the cardiac chambers at the time of death.
Perfusion Conditions
The hamsters were anesthetized with ether, and the hearts were excised rapidly through a midline sternotomy and perfused within 30-60 seconds. The isolated hearts, paced by a Medtronic model 5320 pulse generator (Medtronic Inc., Minneapolis, Minn.) at a constant rate of 220 beats/min, were perfused by a modified Langendorff method.'1 All hearts were perfused at a constant perfusion pressure of 140 cm H20 for 15 minutes to reach a steady state before beginning the experiment. The hearts (stable for 2 hoursl6) first were perfused with either glucose or pyruvate, and then the media was switched to the alternate. All hearts were perfused with a modified Krebs-Henseleit solution containing (mM) NaCl 117, KCl 4.3, CaCl2 2.0, MgCl2 1.2, K2HPO4 0.1, NaHCO3 25, EDTA 0.5, pyruvate 10, or glucose 15, as well as 10 mg/i albumin. The phosphate was too low to be detected by nuclear magnetic resonance (NMR) methods. The medium was bubbled with 95%02-5% CO2 at 25°C, and the temperature was raised to 35°C subsequent to flushing with gases to dissolve maximum oxygen in the perfusate. 15 Temperature was monitored with in-line thermocouples and controlled with specially designed heat exchangers.17 The oxygen tension of the perfusate was maintained at approximately 650 mm Hg.
Physiological Measurements
Arterial samples were aspirated from the aortic chamber, and venous samples were drawn from a catheter introduced into the right ventricular outflow tract for oxygen measurements (model 165/2 gas analyzer, Corning Glassworks, Medfield, Mass.). Pao, was measured, and the myocardial oxygen consumption was calculated as the product of coronary flow and coronary oxygen extraction.15 Coronary flow was determined by collecting the effluent of the right ventricle for 1 minute.
31P Magnetic Resonance Spectroscopy
31P NMR spectroscopy of the beating isolated perfused heart was obtained on a 5.6-T vertical 76-mm bore magnet as described previously.'8 31p_ NMR spectra were obtained without proton decoupling at 97.3 MHz, using a Model 1180 Nicolet computer (Nicolet Instrument Corp., Madison, Wis.), a pulse programmer, and a high-resolution 20-mm broad-band probe. Pulse angle was 600, recycle time 1.25 seconds, and spectra width 4,000 Hz. Spectra were obtained by signal averaging 512 free induction decays during a 10-minute period. The signal-to-noise ratio was approximately 30: 1. Chemical shifts are referred to the resonance position of phosphocreatine (PCr). The pH was determined from the chemical shift in relation to the resonance of PCr by using a chemical shift titration curve of pH-dependent inorganic phosphate (Pi) to PCr peak difference as described earlier. 18 The peaks characteristic of Pi, PCr, and phosphate groups of adenosine were identified. Each spectrum and the corresponding areas were numerically integrated after the baseline was defined. The phosphate percent then was calculated for Pi, PCr, and 8-ATP by dividing each individual peak area by the sum of the areas for all three peaks. The corrected molar ratio of phosphate obtained from MP-NMR was converted to concentration based on standardized high-performance liquid chromatographic analyses of freeze-clamped tissue as described previously.'1021 Extracellular space was calculated as described previously19 by adding K[CoEDTA] to the perfusate at a concentration of 0.6 mM. Millimolar concentration of nucleotides obtained from chromatographic analyses of freeze-clamped tissue then was converted to millimolar cytosolic fraction after adjusting for extracellular space.18 '19 Surface Fluorometry With Indo 1 Fluorescence excitation was provided by a 100-W mercury vapor lamp, through a 365 + 10 nm discriminating filter and a custom-made silica fiber-optic cable (Welch Allyn, Inc., Skaneateles Falls, N.Y., designed for assessing indo 1 excitation and emission), onto a circular epicardial area of 38.5 mm2 of the left ventricular septum, after the free wall of the right ventricle was stripped away.'1 The emitted fluorescence was collected by a coaxial cable of 300 quartz fiber optics, divided by a beam splitter, and then was filtered at 400+5 and 510±+12.5 nm. A direct digital readout of intensity values and ratios was recorded on the computer through software, giving 100 points per cardiac cycle, thus allowing for precise determination of maximum and minimum ratios. The fluorescent intensity ratio of F400/F510 also was displayed on the Gould recorder (Gould Instruments, Cleveland, Ohio) simultaneously with left ventricular pressure for monitoring the influx of Ca'+ in relation to depolarization as timed by the electrocardiogram. 14 The fluorometer was offset for autofluorescence (510 and 400 nm) of the heart before labeling. A standard curve was derived from known concentrations of Ca2' and indo 1 in a balloon in the left ventricular chamber of the unlabeled heart. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] 16 The latter was obtained by placing a balloon inside the left ventricular chamber of the nonlabeled heart, adding known concentrations of Ca2' buffered with EGTA, and the free dye (5 x 10`M indo 1), exciting at 365 nm, and assessing voltage for the intensity ratios of 510 and 400 nm emission after the emission was filtered by the septum. The fiber optics were placed on the right ventricular side of the septum after stripping away the free wall of the right ventricle." The balloon then was removed and the heart labeled with fluorescent dye. Indo 1-AM was solubilized (6 mg) in a mixture of dimethyl sulfoxide/ pluronic F-127 (25% wt/vol) and added to Krebs-Henseleit solution (600 ml) containing 1% calf serum. The heart was perfused 30 minutes with indo 1-AM in Krebs-Henseleit medium as described above except pyruvate was used as the substrate, followed by a 30-45-minute washout with glucose as the substrate. Previous studies in our laboratory have shown the loading is better with pyruvate as the substrate as compared with glucose."1-'4 Loading augments fluorescence of the heart 10-fold. Ca'2 estimation was in the range of linearity from 10`to 10-6 M, giving linear ratios between 0.50 and 1.00. The inflection point of the [Ca'2] concentration curve in an intraventricular chamber balloon filtered by myocardial tissue gave a value the same as that obtained theoretically.
Statistical Analysis
Values are reported as mean+±SD. To detect significant differences between the groups, Scheffe's test for multiple contrasts by the analysis of variance was applied, and Student's t test was used to detect significant differences within a group. The null hypothesis was rejected at the 95% level, considering a value of p <0.05 as significant.
Results Figure 1A is a representative spectrum of fluorescent changes in a normal hamster heart. The ratio that represents free [Ca2"]i is shown on the first channel. Developed pressure is displayed on the second channel and the electrocardiogram on the third channel. Intracellular calcium peaks at approximately half time to peak pressure and coincides with depolarization as it traverses through the heart. A similar representative tracing of the cardiomyopathic hamster heart perfused with pyruvate is given in Figure 1C . There was no calibration of the dynograph channels for fluorescence emission, because digital voltage readout was recorded on the computer for calculation of intracellular calcium. In Figure 1B , a healthy hamster heart demonstrates no change in calcium transients, diastolic calcium, or developed pressure when the substrate was switched from pyruvate to glucose. On the other hand, the cardiomyopathic hamster heart, in late failure, showed a severe increase in diastolic calcium and diastolic pressure when the perfusate was switched from pyruvate to glucose ( Figure 1D ). In many cases, the diastolic calcium was so high when the cardiomyopathic hamster heart was perfused with glucose that one could not discern calcium transients because the dye was saturated. In less severe cases of heart failure in the 00 0'-ULL Because of the shape of healthy hamster hearts, we were not able to succeed in assessing [Ca2+]i in control hamsters. Values are mean-+-SD; n=5. NMR, nuclear magnetic resonance; HPLC, high-performance liquid chromatography; PME, phosphomonoester sugars; PP, phosphorylation potential. cardiomyopathic hamster, the increase in developed pressure and calcium transients was less ( Figure 1E ).
These data are summarized in Table 1 .
In healthy hamster hearts, there was no significant difference in hemodynamics when the hearts were perfused with glucose versus pyruvate. On the other hand, cardiomyopathic hearts showed a significant difference in developed pressure (p<0.01), oxygen consumption (p<0.01), and diastolic pressure (p<O.Ol) when perfused with glucose versus pyruvate. Similarly, there was no significant difference in energy metabolites assessed by 31P-NMR in healthy hamster hearts when perfused with glucose versus pyruvate. However, the cardiomyopathic hamster hearts showed a significant difference in phosphomonoester sugars (p<0.Ol), [pH]i (p<0.O5), and the phosphorylation potential (p<O.O5) when perfused with glucose versus pyruvate (Table 1 ). There was no significant difference in diastolic or systolic calcium in the healthy hamster heart, whereas the cardiomyopathic hamster heart showed a significant difference (p<<O.O1) in both values when perfused with glucose versus pyruvate. Figure 2A demonstrates premature ventricular contractions in a healthy hamster heart. Contractions 1, 3, and 5 are premature contractions with diminished pressure development. Contractions 2, 4, and 6 are potentiated postextrasystolic contractions. Incomplete relaxation ending in a high diastolic calcium is coupled with a lower pressure on the subsequent premature beat. With increasing prematurity, the diastolic calcium is high at the onset of contraction as at arrow 5, and there is an associated high diastolic pressure as shown at arrow 5 on the fourth channel. During the postextrasystolic pause, there is a more complete relaxation and a low diastolic calcium as shown by arrow 6 (first three channels). This results in a higher peak developed pressure as shown at arrow 6 on the fourth channel.
A. Healthy Hamster (Pyruvate) 1 beats. An increase in diastolic calcium preceding the premature beat is associated with a decrease in developedpressure of those beats (1, 3, 5 Figure 2B demonstrates coupled ventricular extrasystoles in cardiomyopathic hamster heart perfused with glucose. Extrasystoles are seen in runs of two (arrows 1 to 2 and 3 to 4) and three (arrows 5-7). Incomplete relaxation and high diastolic calcium are accompanied by a high diastolic pressure and a decrease in peak developed pressure. Figure 2C shows premature ventricular contractions in the cardiomyopathic hamster heart perfused with pyruvate. With a premature beat, incomplete relaxation results in a higher diastolic calcium and a lower developed pressure, but not as severe a rise in diastolic pressure.
As observed in healthy hamster hearts (Figure 2A ), during the postextrasystolic pause, there is a more complete relaxation, a low diastolic calcium, and a subsequently higher developed pressure ( Figure 2C ). Discussion Glycolysis is slow in the heart, limiting delivery of pyruvate to the mitochondria.10,20,21 A rise in Ca21 and H' depresses glycolysis, as observed in isch-emia16,22 and cardiomyopathy.10,23 The decrease in glycolysis most likely is due to Ca2' and H' inhibition of phosphofructokinase,24,25 a rate-limiting enzyme in glycolysis.24,25 Phosphomonoester sugars accumulate when glycolysis is inhibited. 26 An accumulation of phosphomonoester sugars in association with an inhibition in glycolysis has been demonstrated with ischemia16 and heart failure in the cardiomyopathic hamster heart.12 With an inhibition in glycolysis and limited delivery of pyruvate to the mitochondria, there is a decrease in oxygen consumption10 and depressed mitochondrial activity.10 The rise in phosphomonoester sugars, the decrease in the phosphorylation potential, and the low oxygen consumption when the myopathic heart is perfused with glucose as the substrate indicate that glycolysis is inhibited in the cardiomyopathic hamster heart. (Figure 3 
